New eye drops could help kids with lazy eye that Won't go away
NCT ID NCT07554131
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether adding echothiophate iodide eye drops to standard atropine therapy can improve vision in children aged 3 to 18 with refractory amblyopia (lazy eye that hasn't improved with standard treatment). Twenty participants will use atropine nightly for 12 weeks, and if no improvement after 4 weeks, they'll also use echothiophate drops in the weaker eye for 8 weeks. The goal is to see if this combination can boost visual acuity and depth perception.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Echothiophate iodide eye drops
What this could lead to
If it works, this could offer a new treatment option for children with lazy eye that hasn't improved with standard therapy, potentially improving vision and depth perception.
What could go wrong
This is a small early-phase trial with only 20 participants, so results may not apply to all children. The drug may cause side effects like eye irritation or blurred vision, and it's unclear if benefits will last after stopping treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for REFRACTORY AMBLYOPIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Dean McGee Eye Institute
Oklahoma City, Oklahoma, 73104, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact